A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial-Reference-Cited by-同舟云学术

A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial

Published:2016-04-01 Issue:31 Volume:7 Page:49099-49106
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Spears Melanie¹²,Lyttle Nicola¹,D’Costa Alister¹³,Chen Bingshu E.⁴,Yao Cindy Q.¹³,Boutros Paul C.³⁵⁶,Burnell Margot⁷,Levine Mark N.⁸,O’Brien Patti⁴,Shepherd Lois⁴,Bartlett John M.S.¹²⁹

Affiliation:

1. Transformative Pathology, Ontario Institute for Cancer Research, MaRS Centre, Toronto, ON, Canada

2. Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada

3. Informatics and Bio-Computing, Ontario Institute for Cancer Research, MaRS Centre, Toronto, ON, Canada

4. NCIC Clinical Trials Group (NCIC CTG) and Queen's University, Kingston, ON, Canada

5. Department of Medical Biophysics, University of Toronto, Toronto, ON Canada

6. Department of Pharmacology & Toxicology, University of Toronto, Toronto, ON Canada

7. Saint John Regional Hospital, Saint John, MB, Canada

8. Ontario Clinical Oncology Group, McMaster University, Hamilton, ON, Canada

9. Edinburgh Cancer Research UK Centre, MRC IGMM, University of Edinburgh, Edinburgh, UK

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Centromere 17 copy number gain reflects chromosomal instability in breast cancer;Scientific Reports;2019-11-29

2. Clinical Implications of Chromosomal Instability (CIN) and Kinetochore Abnormalities in Breast Cancers;Molecular Diagnosis & Therapy;2019-08-01